Table 2.
Prevalence of systemic comorbidities and oral medicine use.
| Cases | % | Age (Average ± SD) | Female (%) | Male (%) | ||
|---|---|---|---|---|---|---|
| Total | 449 | 62.6 ± 15.6 | 386 (86.0) | 63 (14.0) | ||
| Systemic comorbidity *1 | (−) | 230 | 51.2 | 56.3 ± 16.1 | 195 (84.8) | 35 (15.2) |
| (+) | 219 | 48.8 | 69.2 ± 12.1 | 191 (87.2) | 28 (12.8) | |
| Details *2 | Hypertension | 108 | 24.1 | 73.1 ± 10.8 | 91 (84.3) | 17 (15.7) |
| Insomnia | 67 | 14.9 | 71.0 ± 11.3 | 59 (88.1) | 8 (11.9) | |
| Depression | 20 | 4.5 | 64.9 ± 13.5 | 19 (95.0) | 1 (5.0) | |
| DM | 16 | 3.6 | 70.6 ± 11.6 | 14 (87.5) | 2 (12.5) | |
| RA | 15 | 3.3 | 70.4 ± 8.4 | 15 (100.0) | 0 (0.0) | |
| Others | 113 | 25.2 | 68.1 ± 12.4 | 105 (92.9) | 8 (7.1) | |
| Oral medicine *2 | Antihypertensive | 98 | 21.8 | 73.2 ± 11.1 | 82 (83.7) | 16 (16.3) |
| Sedative | 55 | 12.2 | 70.9 ± 11.1 | 48 (87.3) | 7 (12.7) | |
| Antidepressant | 20 | 4.5 | 64.9 ± 13.5 | 19 (95.0) | 1 (5.0) | |
| Others | 147 | 32.7 | 68.5 ± 12.4 | 134 (91.2) | 13 (8.8) |
DM, diabetes mellitus; RA, rheumatoid arthritis; SD, standard deviation. *1: (+) indicates more than one comorbidity selected among hypertension, insomnia, depression, DM, RA or others. *2: multiple answers allowed.